BioSpace News Archive

Year

• 2005
• 2006
• 2007
• 2008
• 2009
• 2010
• 2011
• 2012
• 2013
• 2014
• 2015
• 2016
• 2017
• 2018
• 2019
• 2020
• 2021
• 2022
• 2023
• 2024
• 2025
• 2026

Month

• January
• February
• March
• April
• May

Day

• 1
• 2
• 3
• 5
• 6
• 7
• 8
• 9
• 10
• 12
• 13
• 14
• 15
• 16
• 17
• 19
• 20
• 21
• 22
• 23
• 24
• 26
• 27
• 28
• 29
• 30

• Press Releases

  Ecuador Free of Rabies project accelerates progress toward eliminating dog-mediated rabies supported by Boehringer Ingelheim’s Stop Rabies program

  April 9, 2026

   · 

  4 min read
• Press Releases

  Medicenna Therapeutics Appoints Dr. Nageatte Ibrahim as Chief Medical Officer

  April 9, 2026

   · 

  7 min read
• Press Releases

  JUNO OTC, A WHOLLY-OWNED SUBSIDIARY OF LSL PHARMA GROUP, SIGNS BINDING TERM SHEET WITH INSTAPILL PRIVATE LIMITED TO SUPPLY PRIVATE LABEL LORATADINE 10 MG RDT IN CANADA

  April 9, 2026

   · 

  4 min read
• Press Releases

  Seres Therapeutics to Present at CARB-X Investor Day

  April 9, 2026

   · 

  6 min read
• Press Releases

  OncoC4 announces first participant’s dosing in Phase 1/2 clinical trial of ONC-841 for the treatment of Alzheimer’s disease

  April 9, 2026

   · 

  2 min read
• Press Releases

  AllRock Bio Doses First Patients in Phase 2a Trial of ROC-101 for Pulmonary Hypertension

  April 9, 2026

   · 

  4 min read
• Press Releases

  Nkarta to Participate in Needham Virtual Healthcare Conference

  April 9, 2026

   · 

  1 min read
• Press Releases

  Cerevance to Present Positive Phase 2 Solengepras Data in Parkinson’s Disease at the American Academy of Neurology 2026 Annual Meeting

  April 9, 2026

   · 

  4 min read
• Press Releases

  Invivyd Announces REVOLUTION Program Progress and Advancement of Novel, Potential First- and Best-in-Class Measles Monoclonal Antibody Candidate VMS063 for Treatment and Prevention of Measles

  April 9, 2026

   · 

  15 min read
• Press Releases

  Boehringer Ingelheim to evaluate innovative combination of DLL3‑targeting T‑cell engager plus PD‑L1/VEGF‑A bispecific antibody in small cell lung cancer

  April 9, 2026

   · 

  4 min read